• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黎巴嫩幽门螺杆菌对甲硝唑、克拉霉素、阿莫西林和四环素的耐药率

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon.

作者信息

Sharara Ala I, Chedid Marwan, Araj George F, Barada Kassem A, Mourad Fadi H

机构信息

Department of Internal Medicine, Box 11-0236/16B, American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

Int J Antimicrob Agents. 2002 Feb;19(2):155-8. doi: 10.1016/s0924-8579(01)00482-4.

DOI:10.1016/s0924-8579(01)00482-4
PMID:11850169
Abstract

The aim of this study was to determine the prevalence of antimicrobial resistance amongst Helicobacter pylori isolates cultured from gastric biopsies taken during routine endoscopies at the American University of Beirut Medical Center in Lebanon. Fifty-four consecutively recovered H. pylori isolates were tested against metronidazole, clarithromycin, tetracycline and amoxycillin using the epsilometer test. Resistance to metronidazole (MIC > 8 mg/l) was found in 29.5% of the isolates while resistance to clarithromycin (MIC > or =0.25 mg/l) and tetracycline (MIC > or =4 mg/l) was low (4 and 2%, respectively). All isolates were susceptible to amoxycillin (MIC < or =8 mg/l). These findings are comparable with those reported from Europe and the United States. The prevalence of metronidazole resistance in our study was lower than that from other parts of the Middle East and the developing world.

摘要

本研究的目的是确定从黎巴嫩贝鲁特美国大学医学中心常规内镜检查时采集的胃活检组织中培养出的幽门螺杆菌分离株的抗菌药物耐药率。使用埃普西隆测定法对连续获得的54株幽门螺杆菌分离株进行甲硝唑、克拉霉素、四环素和阿莫西林药敏试验。29.5%的分离株对甲硝唑耐药(最低抑菌浓度>8mg/l),而对克拉霉素(最低抑菌浓度>或=0.25mg/l)和四环素(最低抑菌浓度>或=4mg/l)的耐药率较低(分别为4%和2%)。所有分离株对阿莫西林敏感(最低抑菌浓度<或=8mg/l)。这些结果与欧洲和美国报道的结果相当。我们研究中甲硝唑耐药率低于中东其他地区和发展中世界。

相似文献

1
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon.黎巴嫩幽门螺杆菌对甲硝唑、克拉霉素、阿莫西林和四环素的耐药率
Int J Antimicrob Agents. 2002 Feb;19(2):155-8. doi: 10.1016/s0924-8579(01)00482-4.
2
High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.从西班牙儿童中分离出的幽门螺杆菌临床菌株对克拉霉素和甲硝唑的耐药率很高。
Rev Esp Quimioter. 2009 Jun;22(2):88-92.
3
Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.1999 - 2003年阿拉斯加对阿拉斯加原住民幽门螺杆菌分离株的抗菌药物耐药性进行哨点监测。
Helicobacter. 2006 Dec;11(6):581-8. doi: 10.1111/j.1523-5378.2006.00462.x.
4
Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime.以色列分离出的幽门螺杆菌对甲硝唑、克拉霉素、四环素、阿莫西林和头孢克肟的耐药性。
J Antimicrob Chemother. 2002 Jun;49(6):1023-6. doi: 10.1093/jac/dkf041.
5
Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria.从尼日利亚乔斯分离出的幽门螺杆菌的药敏试验。
Trans R Soc Trop Med Hyg. 1999 Nov-Dec;93(6):659-61. doi: 10.1016/s0035-9203(99)90089-5.
6
Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.俄罗斯联邦斯摩棱斯克地区幽门螺杆菌分离株的抗菌药物耐药性动态。
Helicobacter. 2018 Dec;23(6):e12545. doi: 10.1111/hel.12545. Epub 2018 Oct 16.
7
[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].[36株幽门螺杆菌临床分离株对四种一线抗生素的敏感性及毒力因子]
Rev Esp Quimioter. 2006 Mar;19(1):34-8.
8
Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults.以色列儿童和成人中幽门螺杆菌对四环素、阿莫西林、克拉霉素和甲硝唑的耐药性。
J Antibiot (Tokyo). 2014 Aug;67(8):555-7. doi: 10.1038/ja.2014.38. Epub 2014 Apr 30.
9
Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.印度患者幽门螺杆菌临床分离株抗菌药物耐药模式的地理差异:多中心研究。
J Gastroenterol Hepatol. 2003 Dec;18(12):1373-8. doi: 10.1046/j.1440-1746.2003.03174.x.
10
Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain.
J Antimicrob Chemother. 1997 Aug;40(2):279-81. doi: 10.1093/jac/40.2.279.

引用本文的文献

1
A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population.一项随机、前瞻性交叉研究,比较黎巴嫩人群样本中铋剂四联疗法与10天联合疗法后的根除率。
Curr Ther Res Clin Exp. 2025 Apr 14;102:100791. doi: 10.1016/j.curtheres.2025.100791. eCollection 2025.
2
antibiotic sensitivity pattern in dyspeptic patients in Kano, Nigeria.尼日利亚卡诺消化不良患者的抗生素敏感性模式
S Afr J Infect Dis. 2019 Oct 17;34(1):125. doi: 10.4102/sajid.v34i1.125. eCollection 2019.
3
Helicobacter pylori eradication in West Asia: a review.
西亚地区幽门螺杆菌的根除:一项综述。
World J Gastroenterol. 2014 Aug 14;20(30):10355-67. doi: 10.3748/wjg.v20.i30.10355.
4
Low rate of recurrence of Helicobacter pylori infection in spite of high clarithromycin resistance in Pakistan.尽管巴基斯坦克拉霉素耐药率很高,但幽门螺杆菌感染的复发率仍然较低。
BMC Gastroenterol. 2013 Feb 21;13:33. doi: 10.1186/1471-230X-13-33.
5
Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran.伊朗德黑兰消化不良患者分离的幽门螺杆菌的抗生素药敏谱。
Saudi J Gastroenterol. 2011 Jul-Aug;17(4):261-4. doi: 10.4103/1319-3767.82581.
6
Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes.对四环素耐药的临床幽门螺杆菌分离株,其16S rRNA编码基因有无突变。
Antimicrob Agents Chemother. 2005 Feb;49(2):578-83. doi: 10.1128/AAC.49.2.578-583.2005.
7
Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt.从埃及儿童中分离出的幽门螺杆菌对甲硝唑普遍具有高水平原发性耐药。
J Clin Microbiol. 2004 Oct;42(10):4832-4. doi: 10.1128/JCM.42.10.4832-4834.2004.
8
Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States.美国幽门螺杆菌感染者的抗菌药物耐药发生率及风险因素
Emerg Infect Dis. 2004 Jun;10(6):1088-94. doi: 10.3201/eid1006.030744.